BEXIMCO PHARMA.GDR REGS 1 Net Asset Quality Index
BEXIMCO PHARMA.GDR REGS 1 net asset quality index. BEXIMCO PHARMA.GDR REGS 1 (R2WA) has a Net Asset Quality Index of 72.7% as of December 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €73.80 Billion minus total liabilities of €20.17 Billion yields net assets of €53.63 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of BEXIMCO PHARMA.GDR REGS 1 for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of BEXIMCO PHARMA.GDR REGS 1 (2021–2024)
Net asset quality index of BEXIMCO PHARMA.GDR REGS 1 from 2021 to 2024. This chart shows how BEXIMCO PHARMA.GDR REGS 1's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of December 2024, the index stands at 72.7%, representing net assets of €53.63 Billion against total assets of €73.80 Billion EUR. Check tangible equity quality of BEXIMCO PHARMA.GDR REGS 1 to evaluate the tangible quality of the company's equity base.
BEXIMCO PHARMA.GDR REGS 1 Net Asset Quality Index by Year (2021–2024)
BEXIMCO PHARMA.GDR REGS 1 net asset quality index by year from 2021 to 2024. The table below presents the year-by-year Net Asset Quality Index for BEXIMCO PHARMA.GDR REGS 1 from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see BEXIMCO PHARMA.GDR REGS 1 (R2WA) total market value.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 74.8% | €51.90 Billion | €69.34 Billion | €17.44 Billion | ▲ +6.0 pp |
| 2023 | 68.9% | €47.62 Billion | €69.16 Billion | €21.54 Billion | ▲ +1.4 pp |
| 2022 | 67.5% | €44.64 Billion | €66.15 Billion | €21.51 Billion | ▼ -4.0 pp |
| 2021 | 71.5% | €37.36 Billion | €52.25 Billion | €14.88 Billion | — |